Background.-Despite the high level of individual and societal burden resulting from headache disorders, the National Institutes of Health (NIH) has funded relatively little research on these disorders.
1
Migraine headaches alone result in more than 1% of the total US disability burden. 2 At least 50% of migraine sufferers are severely disabled, many requiring bed rest, during individual migraine attacks lasting hours to days. 3 A conservative estimate of total US annual economic costs from headache disorders is $31 billion. 4, 5 Despite the significant burden that headache disorders place on individuals and society, federal funding of headache research is minimal. The National Institutes of Health (NIH) is estimated to expend approximately $13 million annually on headache research. 2 This accounts for less than 0.05% of the total NIH budget. Headache research is not considered in the NIH estimates of disease-specific grant expenditures or economic costs of illness. There are relatively few request for applications (RFAs) and program announcements (PAs) related to headache research.There is no NIH institute, center, or standing study section focusing on pain, let alone one focusing specifically on headache disorders. Furthermore, no intramural headache research program exists at the National Institute for Neurological Disorders and Stroke (NINDS).
The aim of this study is to better define the current patterns of NIH funding of research on headache disorders.
METHODS
The Computer Retrieval of Information on Scientific Projects (CRISP) database was employed. 6 CRISP is a searchable database of federally funded biomedical research projects that is maintained by the NIH. It includes projects funded between 1972 and the present time. Although the majority of projects are funded by the NIH, the database also includes projects funded by other federal institutes including: Substance Abuse and Mental Health Services, Health Resources and Services Administration, Food and Drug Administration, Centers for Disease Control and Prevention, Agency for Health Care Research and Quality, and the Office of Assistant Secretary of Health.
The CRISP database was searched using the terms "Migraine" or "Headache" or "Trigeminovascular" inclusive of 1987 to November 2007. The titles and abstracts of the resulting projects were reviewed to identify headache-related studies. Once these projects were identified, the following information was collected:title of project, principal investigator (PI),study site, grant mechanism, funding institute or center, headache type being studied, duration of funding, research focus (pathophysiology, treatment, diagnosis, novel therapeutics), subject type (human, animal), and peer-review study section. E-mail questionnaires were sent to each of the PIs in order to determine whether they had ever been or currently were a member of the American Headache Society, and whether they have ever served on an NIH study section. The e-mail was sent a second time to all PIs who did not respond to the first e-mail. American Headache Society membership was also determined by reviewing membership directories from the last 5 years.
National Institutes of Health funding of headache research was compared with the funding of 10 other chronic disorders including epilepsy, asthma, diabetes, ovarian cancer, stroke, arthritis, multiple sclerosis, Parkinson's disease, hepatitis C, and schizophrenia.These 10 disorders were among 32 potential comparator disorders or disease categories that were listed on both the "NIH Estimates of Funding for Various Diseases, Conditions, Research Areas" 7 and the World Health Organization estimates of annual United States disability-adjusted life years (DALYs). 8 These 10 disorders were selected because published estimates could also be readily obtained for both their population prevalences and their annual US economic costs. Comparisons were made for total 2007 NIH funding, funding per person with the disorder, funding per DALY, and funding per $1000 costs to society from the disorder. Further methods for determining this information are described in the caption of Table 1 .
To obtain the amounts of NIH awards for grants identified in CRISP searches, the Tracking Accountability in Government Grants System (TAGGS) database (http://taggs.hhs.gov/) was searched. All grants identified by CRISP search for key words "migraine," "headache," or "trigeminovascular" were identified as likely awarded in FY 2007 and with clear relevance for headache disorders research. TAGGS searches identified awards amounts for these grants. Research project grants (Rs) were the most frequent, accounting for 61 (55%) of the grants. There were 14 (12.6%) program projects and centers grants (P), 11 (9.9%) general clinical research center projects (M), 10 (9%) career development awards (K), 7 (6.3%) intramural research projects (Z), 4 (3.6%) fellowship program awards (F), and 4 (3.6%) research related programs (S) (Fig. 2) .
RESULTS

The
Migraine was studied in 77 (69.4%) of the projects, headache "not otherwise specified" in 23 (20.7%), tension-type headache in 4 (3.6%), cluster headache in 2 (1.8%), and other headache types in 5 (4.5%) (1 project each for medication-overuse headache, idiopathic intracranial hypertension, giant cell arteritis, cerebrospinal fluid leak headache, and Chiari malformation headache). Human subjects were studied in 64 (64%) projects, animals in 39 (39%) projects, and 3 projects studied both human subjects and animals. This information was unavailable for 11 studies. Children were included in 6 (5.4%) projects. Pathophysiology of headache was studied in 54 (48.6%) projects, treatment in 37 (33.3%), diagnosis in 19 (17.7%), and novel therapeutics in 9 (8.1%). 2 Annual US economic costs attributable to all headache disorders were derived by adding the indirect costs of all headache disorders ($20 billion) 4 to the direct costs for migraine excluding over-the-counter medication costs ($11 billion). 5 This is an underestimate of true costs since neither direct costs for non-migraine headache disorders (eg, chronic daily headache) nor the costs for over-the-counter medications for all headache disorders (which may total $1 billion 5 ) are included in this total. All other data were derived from sources as cited. MS = multiple sclerosis; -= data not available. (Fig. 3) . Study sections providing peer review of grant applications (n = 86 projects) included special emphasis panels (44.2%), neurological sciences (10.5%), behavioral medicine (10.5%), somatosensory and chemosensory systems (8.1%), training grant and career development (7.0%), molecular neuropharmacology and signaling (2.3%), and nursing (2.3%).
The majority of PIs (n = 72, 77.4%) worked at academic institutions, with an equal split (n = 7, 7.5% each) among investigators working at the NIH, at non-academic private institutions, or for industry. E-mail responses were received from 33 (35%) of the PIs. From these responses, as well as from American Headache Society membership directories for the last 5 years, it was determined that at least 28 (30.1%) were currently and at least 30 (32.3%) were at some time members of the American Headache Society. E-mail responses from 14 PIs stated that they had served on an NIH study section at some time.
The TAGGS search of grants awarded in FY 2007, and relevant to headache disorders by CRISP, totaled $6,832,948, with a mean of $235,618 per grant. Two grants identified in CRISP documentation as likely awarded in FY 2007 could not be identified in the TAGGS database. Therefore, $6,832,948 should be regarded as a minimum estimate of the total NIH funding for headache disorders in FY 2007.
The (Table 1 ; Fig. 4 ). The 2007 NIH funding per person with the disorder was calculated for migraine and the 10 comparator disorders. Funding for the comparator disorders ranged from $7.21 to $588.57 per person with the disorder (Fig. 5 (Fig. 7) .
DISCUSSION
Headache disorders are highly prevalent and result in significant individual and societal burden. However, governmental funding of headache research is minimal in the United States and Europe. 26, 27 The NIH has not disclosed an estimate of the total funding allocations for migraine or headache disorders. We previously reported a rough estimate of recent annual NIH funding for headache research as approximately $13 million dollars. assumes that all "migraine" documents are truly relevant to headache research and that the estimated mean funding per "migraine" document is similar for other disorders. Review of the CRISP documents retrieved for"migraine"indicates that many grants are marginally related to headache research. Also, the mean headache grant size ($235,618) retrieved from TAGGS was smaller than the mean non-headache grant size ($318,000) used to derive the $13 million estimate. 2 Use of the $13 million figure as indicative of funding for all headache research also assumes that NIH funds very little non-migraine headache research. Our data indicate that 69% of NIH headache research grants studied migraine, and 21% of these grants did not specify the headache type studied, many of which could have been migraine-related as well. 28 The $13 million total headache funding figure is likely an overestimation of total NIH funding for headache research. Our TAGGS database analysis indicates a minimum level of FY 2007 NIH funding of headache research of $6,832,948.This number is likely an underestimation of the total funding since (1) the funding amounts for some grants identified by CRISP search could not be found in the TAGGS database; and (2) we excluded from our overall analysis some grants that included any of the key words "migraine," "headache," or "trigeminovascular," but were judged to be marginally related to headache research on close reading of the grant abstracts. The NINDS estimates their FY 2007 funding for all headache research to have been $6.206 million (Dr. Linda Porter, NINDS, personal communication). Since our analysis indicates that NINDS accounts for approximately 64% of all NIH headache research grants, $9.7 million may be a closer estimate of the total NIH FY 2007 research funding for headache disorders.
For the purposes of our comparative analyses, we used the estimate of $13 million since we believed this Investigator-initiated research is the core activity supported by NIH; the peer-review system is intended to ensure that only the most promising of these projects receive funding. However, the NIH is also structured to encourage research into particular areas where it is most needed. Priorities for funding are expressed by NIH through programmatic vehicles such as RFAs and PAs, or by establishment of branches, institutes, or centers. Important factors taken into consideration when prioritizing NIH research programs include the need to counter emerging public health threats and the desire to capitalize on unique opportunities such as the development of novel research techniques or breakthroughs which can accelerate the advancement of particular fields.
Relative burden of disease is another important consideration in prioritizing research. We calculated NIH-funded headache research relative to 3 commonly recognized measures of disease burden: population prevalence, DALYs, and economic costs. By each of these measures, headache research is grossly underfunded relative to other chronic disorders. While the DALY metric takes into account "lost years" due to disability, some have argued that the most meaningful measure of disease burden is mortality and that headache disorders are not fatal illnesses. In fact, migraine with aura is a significant risk factor for suicide attempts 29 and may also account for more than 1400 excess cardiovascular deaths in the US annually. 30 Burden of illness is a central concern of the NINDS; the stated primary mission of the institute is to ". . . reduce the burden of neurological disease . . .". 31 In light of this mission, the inattention to headache research by NINDS is particularly striking.
CONCLUSIONS
Search of the CRISP database indicates that 111 headache research projects from 93 different PIs were funded by the NIH during 1987 to 2007. The majority (55%) of projects are comprised of research project grants (Rs) and at least 69% of grants were related to migraine. NINDS funded a mean of 64% of all NIH research grants on headache disorders since 2002. A comparison of headache disorders to 10 other chronic diseases, relative to 3 measures of disease burden, suggests that current NIH funding of headache research should exceed $103 million annually.
